Shares of SONOVA HOLDING (OTCMKTS:SONVY - Get Free Report) have been assigned a consensus rating of "Reduce" from the nine ratings firms that are currently covering the company, MarketBeat.com reports. Four equities research analysts have rated the stock with a sell recommendation, four have assigned a hold recommendation and one has given a strong buy recommendation to the company.
SONVY has been the subject of a number of research reports. HSBC cut SONOVA from a "buy" rating to a "hold" rating in a research report on Wednesday, May 21st. Barclays cut SONOVA from a "hold" rating to a "strong sell" rating in a research report on Friday, June 20th. Sanford C. Bernstein raised SONOVA from a "hold" rating to a "strong-buy" rating in a research report on Friday, July 18th. Hsbc Global Res cut SONOVA from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, May 21st. Finally, Kepler Capital Markets raised SONOVA from a "strong sell" rating to a "hold" rating in a research report on Friday, June 6th.
Check Out Our Latest Analysis on SONVY
SONOVA Stock Performance
SONVY traded down $0.53 during trading on Thursday, reaching $55.16. 18,288 shares of the stock traded hands, compared to its average volume of 23,168. SONOVA has a fifty-two week low of $52.83 and a fifty-two week high of $77.56. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.27 and a quick ratio of 0.96. The stock's 50-day simple moving average is $59.01 and its two-hundred day simple moving average is $61.34.
SONOVA Increases Dividend
The firm also recently disclosed a dividend, which was paid on Wednesday, July 2nd. Investors of record on Tuesday, June 17th were given a dividend of $0.6243 per share. The ex-dividend date of this dividend was Monday, June 16th. This represents a dividend yield of 99.0%. This is a boost from SONOVA's previous dividend of $0.57.
SONOVA Company Profile
(
Get Free Report)
Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.
Further Reading

Before you consider SONOVA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SONOVA wasn't on the list.
While SONOVA currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.